Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).
In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).
MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.
MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.
Choose MenaQ7® to support your heart health claims with science!
Latest news & videos
- Lynside® Nutritional Yeasts
- News
- Wellness & Immune
- Apr 23, 2025
Lynside® Forte Se+ for Skin Protection Against Sun Exposure
Selenium yeast boosts skin defenses against sun damage by fighting oxidative stress, supporting repair,...
- MenaQ7®
- Mobility & Joint
- MyCondro®
- Apr 17, 2025
Successful Vital Nutrients Symposium:
Shaping the Future of Healthy Aging
The Vital Nutrients Symposium 2025, held in Kassel, Germany, offered an excellent platform to...
- MenaQ7®
- Mobility & Joint
- News
- Apr 09, 2025
Groundbreaking Vitamin K2 Research Presented at the 7th Osteoporosis Congress in Padova (March 19-21, 2025)
Gnosis recently took an important step in advancing the scientific understanding of vitamin K2...
